Dr. Scott Bergman is the Antimicrobial Stewardship Coordinator and Infectious Diseases Pharmacy Residency Director at Nebraska Medicine in Omaha, Nebraska. He is also a Clinical Professor at the University of Nebraska Medical Center, College of Pharmacy. He received his Doctor of Pharmacy from South Dakota State University and completed post-graduate residency training at West Virginia University Hospitals. His passion is in studying and implementing the optimal use of antimicrobials. He is very involved in supporting antimicrobial stewardship across the state of Nebraska and Midwest Region (U.S). Finally, Dr. Bergman is the outgoing President for the Society of Infectious Diseases Pharmacists.

Danielle Brabant-Kirwan is the Clinical Microbiologist at Health Sciences North (HSN) in Sudbury, Ontario. She is the Section Head of Microbiology, the laboratory Biosafety Officer and member of the Antimicrobial Stewardship and Infection Control committees. Dr. Brabant-Kirwan is an AC Diagnostics assessor and Medical Laboratory Scientist member of the AC Diagnostics Accreditation Panel. She is also a member of Ontario’s COVID-19 Genomics Rapid Response Coalition. Prior to joining HSN in 2015, Danielle was trained in Clinical Microbiology in the Laboratory Medicine and Pathobiology program at the University of Toronto. Danielle completed a post-doctoral fellowship at SickKids Hospital in Toronto studying Salmonella typhimurium and was awarded a Governor General’s Gold Medal in 2009 for her PhD thesis on Septic Shock from Laurentian University.

Dr. Tanis Dingle is a clinical microbiologist at Alberta Precision Laboratories - Public Health Laboratory and oversees antimicrobial resistance surveillance and the clinical mycology laboratory. Dr. Dingle currently holds a primary appointment as Clinical Associate Professor in the Department of Pathology and Laboratory Medicine in the Cumming School of Medicine at the University of Calgary. In addition, she is an Assistant Adjunct Professor in the Department of Laboratory Medicine & Pathology in the Faculty of Medicine and Dentistry at the University of Alberta. Dr. Dingle completed her Ph.D at the University of Calgary in the Department of Microbiology and Infectious Diseases and completed her clinical microbiology training at the University of Washington in Seattle, Washington. Dr. Dingle is certified as a diplomate of the American Board of Medical Microbiology and is a Fellow of the Canadian College of Microbiologists. Dr. Dingle sits on the Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Subcommittee and the CLSI Antifungal Susceptibility Testing Subcommittee. Dr. Dingle’s research interests include exploring novel strategies for assessing antimicrobial activity and detecting antimicrobial resistance in the clinical microbiology laboratory. Other areas of research focus are the development of diagnostic methods and algorithms to improve the prognosis of patients with invasive fungal infections and understanding the changing epidemiology of endemic mycoses.

Dr. Dufresne is head of the Mycology Laboratory at the Public Health Laboratory of Province of Quebec since 2012. He completed his MSc and PhD in microbiology/genomics at McGill University from 2002 to 2008, followed with a post-doc in industrial fungal genomics. Dr. Dufresne has been actively involved with CLSI since 2013 and currently serves as the chair of the Antifungal Susceptibility Subcommittee and co-chair of the ECV working group. He also chairs the Canadian Public Health Laboratory Network (CPHLN) Mycology working group. His research interests include antifungal resistance/susceptibility, Candida auris, molecular diagnostics of fungal infections, and the molecular epidemiology of Risk Group 3 dimorphic fungi infections.

Dr. Fattouh received his doctorate in Medical Sciences from McMaster University. He completed a postdoctoral fellowship in Clinical Microbiology from the University of Toronto in 2016 and is a Fellow of the Canadian College of Microbiologists (CCM). Dr. Fattouh joined St. Joseph’s Healthcentre, Toronto, as a Clinical Microbiologist in 2016 and St. Michael’s Hospital as a Clinical Microbiologist and the Director of the Molecular Diagnostics Laboratory in 2017, and is also an assistant professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Dr. Fattouh is part of the board of directors of CACMID and a member of the clinical microbiology whole genome sequencing quality working group led by PHO Laboratories. Dr. Fattouh’s clinical and academic interests include the development and application of novel molecular based diagnostics as well as antimicrobial resistance detection and stewardship.

Graduated from McGill Internal medicine , Microbiology and Infectious Diseases Practiced At Charles Lemoyne Hospital 1989-2007 Since 2007 Medical Director of Infection Control McGill University Health Center Chair of SPIN , Quebec’s surveillance network of Nosocomial infections 1998-2014 Member of CINQ 2000-2021 (Comité des Infections Nosocomiales du Québec) Chair of CNISP 1994-2021

Dr. Victor Leung trained in Internal Medicine at the University of British Columbia and Infectious Diseases and Medical Microbiology at McGill University. He currently works at Providence Health Care in Vancouver and is the Medical Director for Infection Prevention and Control and the Physician Lead for the Antimicrobial Stewardship Program. His focus in the Antimicrobial Stewardship program is to improve diagnosis and prescribing to ensure optimal resource utilization and patient outcomes.

Dr. Tony Mazzulli is the Microbiologist-in-Chief and Infectious Diseases Specialist at Sinai Health and University Health Network, and a consulting Medical Microbiologist for the Public Health Ontario Laboratories. He is a Professor in the Department of Laboratory Medicine and Pathobiology, Faculty of Medicine at the University of Toronto. In addition, he is the Program Director for the Medical Microbiology Residency Training Program and the Postdoctoral Clinical Microbiology Training Program, Faculty of Medicine, University of Toronto, the division head of microbiology in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, the President of the Canadian Association for HIV Clinical Laboratory Specialists (CAHCLS), and the Chair of the Royal College of Physicians and Surgeons of Canada Medical Microbiology Subspecialty Committee. He has published over 200 articles in peer reviewed medical/scientific journals and 5 book chapters.

Katherine Perez works to foster partnerships between antimicrobial stewardship programs (ASPs) and microbiology laboratories by providing tailored guidance and using data to refine and optimize the quality of care. Previously, Katherine helped build a successful ASP across one of the nation’s largest healthcare systems in Houston, TX. By using rapid diagnostics to drive stewardship interventions, Katherine demonstrated the invaluable partnership between pharmacy and the microbiology laboratory.

Dr. Poutanen is a Medical Microbiologist and Infectious Diseases Physician at Sinai Health & University Health Network in Toronto, Canada and an associate professor in the Department of Laboratory Medicine and Pathobiology and Department of Medicine at the University of Toronto. Dr. Poutanen received her Medical Degree from the University of Toronto in 1996 and completed Internal Medicine and Medical Microbiology Residencies at the University of Toronto and an Infectious Diseases Fellowship at Stanford University, California. She received her Masters of Public Health with a focus on Epidemiology from the University of California, Berkeley in 2002. Her broad research interests include: the epidemiology and detection of antimicrobial resistance; the optimization of microbiology laboratory practices using point-of-care tests, rapid diagnostics, automation, and artificial intelligence: and the preparedness and detection of emerging infectious disease threats.

Dr. Stefanovic completed her Medical Degree and internal medicine residency at University of Ottawa, followed by fellowships in infectious diseases and medical microbiology at the University of British Columbia. Her special interests include clinical impact of novel diagnostic/molecular testing, laboratory utilization and diagnosis of infections in immunocompromised hosts.

Paul Bonnar completed his Internal Medicine and Infectious Diseases training at Dalhousie University. He then completed a clinical fellowship in Antimicrobial Stewardship at the University of Toronto. After completing this fellowship, Paul started his position as physician co-lead for the NS Health antimicrobial stewardship program in July 2017. He is a member of the AMMI Canada Antimicrobial Stewardship and Resistance Committee.

Dr. John Conly is a Professor and former Head of the Department of Medicine at the University of Calgary and Alberta Health Services - Calgary and Area, Canada. He is medically trained as a specialist in infectious diseases, and was a past President of the Canadian Infectious Disease Society, past Chairman of the Board for the Canadian Committee on Antibiotic Resistance and a previous Vice Chair for the Canadian Expert Drug Advisory Committee. He is currently the Co-Director for the Snyder Institute for Chronic Diseases at the University of Calgary, a member of the Canadian Expert Advisory Group on Antimicrobial Resistance and a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance. Further, he is the Work Package Lead, Principal Investigator, and Executive Committee member at the AMR – One Health Consortium. He has published over 300 papers and has received multiple career honours in teaching, research, mentorship, innovation and service, including the Ronald Christie Award for outstanding contributions to academic medicine in Canada, the Medal for Distinguished Service from the Alberta Medical Association for outstanding personal contributions to the medical profession and the Order of Canada for pioneering work in antimicrobial resistance, infection control and health innovation. He continues as an active consultant in clinical infectious diseases with current interests which focus on antimicrobial resistance and stewardship, prevention of hospital-acquired infections and novel innovations in healthcare.

Cora Constantinescu is a pediatrician, infectious disease physician and clinical associate professor in Calgary AB. She holds a masters in medical education and specializes in development and study of antimicrobial stewardship education interventions rooted in behavioral change theory. She has applied these skills to battling antimicrobial resistance, promoting appropriate prescribing behaviour as well as combating vaccine hesitancy for healthcare workers and the public

Dr. Rob Kozak completed his PhD in microbiology and immunology at McGill University. Following this he completed post-doctoral fellowships in viral hepatitis and zoonotic viruses at McGill and the Ontario Veterinary College, University of Guelph, respectively. Before entering the clinical microbiology training program at the University of Toronto, he trained at the Special Pathogens Program at the National Microbiology Laboratory in Winnipeg where he studied viral hemorrhagic fevers. In addition to his research on emerging viruses and the One Health concept, his clinical interests focus on using sequencing techniques to investigate antimicrobial resistant organisms. He also serves on the boards of the Canadian College of Microbiologists and the Canadian Association of Clinical Microbiology and Infectious Diseases. He is a clinical microbiology at Shared Hospital Laboratory located Sunnybrook Health Sciences Centre and an Assistant Professor in the department of laboratory medicine and pathobiology at the University of Toronto.

Melissa Kucey is the Regina Antimicrobial Stewardship and Infectious Diseases Pharmacist. She has a degree in both physiology and pharmacy and completed her hospital pharmacy residency in 2015. She has worked as a clinical pharmacist in critical care, general medicine, and now specializes in antimicrobial stewardship and infectious diseases. Melissa thoroughly enjoys her role in antimicrobial stewardship and hopes to continue to create awareness around antimicrobial resistance and educate others on their vital role in helping address this global threat.

Stefanie Lam obtained her B.Pharm and M.Sc. in Advanced Pharmaceutical Care from the Université de Montréal and her PharmD from the University of British Columbia. In 2009, during a 2-year work experience in Singapore, she helped implement a Clinical Pharmacy program on the Internal Medicine ward at the National University Hospital. In 2011, she co-founded JASPRO (Joint Antimicrobial Stewardship Program) at the Jewish General Hospital and is currently its Pharmacy lead. She is also an associate clinician for the Faculty of Pharmacy at the Université de Montréal.

Dr. Brad Langford is a board certified infectious diseases pharmacist and antimicrobial stewardship specialist at Public Health Ontario and Hotel Dieu Shaver Health and Rehabilitation Centre. Brad is also an Assistant Professor at the Dalla Lana School of Public Health at the University of Toronto. His practice and research interests include knowledge translation, antibiotic use surveillance, and evaluation of initiatives to improve the quality and safety of antibiotic use in all health care settings.

Dr. Karen Maxwell is an Associate Professor in the Department of Biochemistry at the University of Toronto. She completed her graduate studies at the University of Toronto, where she studied the viral assembly process of bacteriophage  using structural, biophysical, and genetic approaches. Her postdoctoral word was undertaken at the Ontario Centre for Structural Genomics, applying structural genomics to characterize the genes of unknown function in a variety of bacteriophages. In her own laboratory, Dr. Maxwell studies various aspects of the phage-host evolutionary arms race, including CRISPR-Cas and chemical anti-phage defence. She has published extensively and established a strong track record as a researcher, educator, and mentor. Dr. Maxwell was honoured to receive the Natural Sciences and Engineering Research Council 2020 John C. Polanyi Award for her group’s discovery of chemical anti-phage defence, and was recently appointed the Joan Dixon and Joel Parkes Professor of Biochemistry.

Jeya is dually trained in Infectious Diseases and Medical Microbiology. She is the medical director of Infection Prevention and Control and the Medical Microbiology laboratory at Oak Valley Health where she also provides inpatient and outpatient consultation in Internal Medicine and Infectious Diseases and was the physician lead for the Antimicrobial Stewardship Program during its inception and development. She is the IPAC physician Lead at Public Health Ontario. She is a consulting medical microbiologist with Gamma Dynacare Laboratories.

Jane Parmley is an Associate Professor in the Department of Population Medicine at the University of Guelph. Throughout her career, Jane has worked on complex but fascinating health problems such as antimicrobial resistance and emerging zoonotic diseases with government, non-governmental and university-based organizations. Using a One Health approach in her research, Jane uses systems thinking to consider the many drivers that influence health and the interconnections between humans, animals and our shared ecosystems. She collaborates with other disciplinary experts and knowledge holders to advance the implementation of One Health and find creative solutions to complex health problems

Dr. Kevin Schwartz, MD MSc FRCPC, is the division head for infectious diseases at St. Joseph's Health Centre in Toronto as well as an academic infection control and antimicrobial stewardship physician at Public Health Ontario. He is an assistant professor at the Dalla Lana School of Public Health at the University of Toronto and an adjunct scientist at ICES. His clinical area of interest is adult and pediatric infectious diseases and tropical medicine. His research interests include vaccine preventable diseases and antimicrobial stewardship with a particular focus on improving community antibiotic use to slow the emergence of drug resistant infections.

Dr. Nikki Weckman (ISTEP, ChemE) is the incoming Paul Cadario Chair in Global Engineering at the University of Toronto. Her research focuses on developing the next generation of point-of-care technologies for diagnosing diseases and monitoring outbreaks of drug-resistant infections. She is particularly interested in developing low cost and sustainable diagnostics that can help to improve health equity. Dr. Weckman is joining U of T after completing postdoctoral research at Harvard University and the University of Cambridge. Before her postdoctoral work, Dr. Weckman obtained her PhD in Engineering from the University of Cambridge, her MEng in Chemical Engineering from McGill University and her BASc in Nanotechnology Engineering from the University of Waterloo. Beyond her academic work, Dr. Weckman is co-founder of the start-up 52 North Health, where she is working in the medical diagnostic space to develop low-cost digitally linked technologies that help improve health outcomes and health equity for people receiving chemotherapy

Dr. George Zhanel received his Ph.D. in the Department of Medical Microbiology/Infectious Diseases at the Faculty of Medicine, University of Manitoba and a Doctor of Clinical Pharmacology at the University of Minnesota. He is presently Professor and Associate Head in the Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine and Research Director of the Canadian Antimicrobial Resistance Alliance (CARA). Dr Zhanel is the founding and Chief Editor of the Canadian Antimicrobial Resistance Alliance (CARA) website (www.can-r.com). Dr. Zhanel has published over 1100 papers, chapters and abstracts in the area of treatment and prevention of infectious diseases. He has presented over 1100 lectures as an invited speaker at international, national, and local meetings speaking on the topics of antimicrobial resistant infections as well as treatment and prevention of infectious diseases in Canada, United States, Central and South America, Western and Eastern Europe including Russia, Australia, Southern and Northern Africa, the Middle East and Asia. Dr. Zhanel has received or been nominated for 95 teaching awards including the Canadian Association for Medical Education (CAME) merit teaching award in 2020. Dr. Zhanel is a member of the Who’s Who in Medical Sciences Education (WWMSE). In 2021, he was 1 of 190 Canadian scientists recognized by Web of Science (a global citation database) as a “highly cited researcher”, an honor received by 1 out of 1000 of the worlds scientists. In 2022, he was elected as a fellow of the Canadian Academy of Health Sciences (CAHS) in recognition of sustained excellence in research and teaching within the health sciences. Fellowship in the Academy is considered one of the highest honours for individuals in the Canadian health sciences community